Insider Transactions in Q3 2023 at Prestige Consumer Healthcare Inc. (PBH)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
2,540
-13.75%
|
$147,320
$58.92 P/Share
|
|
Sep 14
2023
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
2,540
+12.09%
|
$76,200
$30.56 P/Share
|
|
Aug 08
2023
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
32,800
-2.78%
|
$2,164,800
$66.47 P/Share
|
|
Aug 08
2023
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,800
+9.76%
|
$1,082,400
$33.5 P/Share
|
|
Aug 01
2023
|
John E Byom Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+4.36%
|
-
|
|
Aug 01
2023
|
Celeste A. Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+19.91%
|
-
|
|
Aug 01
2023
|
James D Arecca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+50.0%
|
-
|
|
Aug 01
2023
|
Sheila Hopkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+8.16%
|
-
|
|
Aug 01
2023
|
Natale S Ricciardi Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+7.81%
|
-
|
|
Aug 01
2023
|
Dawn M. Zier Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+15.79%
|
-
|